Vistagen Therapeutics, Inc.
Clinical trials sponsored by Vistagen Therapeutics, Inc., explained in plain language.
-
New nasal spray could ease public speaking panic in social anxiety
Symptom relief OngoingThis study tests an investigational nasal spray (fasedienol) for quickly reducing anxiety during a public speaking challenge in adults aged 18–65 with social anxiety disorder. Participants receive either the spray or a placebo and rate their distress levels. The goal is to see if…
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:53 UTC
-
Nasal spray could ease public speaking panic in social anxiety
Symptom relief OngoingThis study tests an experimental nasal spray called fasedienol for quickly reducing anxiety during a public speaking challenge in adults with social anxiety disorder. About 238 participants will receive either the spray or a placebo and rate their distress. The goal is to see if …
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC